Granite Investment Partners’s Emergent Biosolutions EBS Stock Holding History

Granite Investment Partners’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-27,604	Closed	-$2.56M	–	284
2021 Q1	$2.56M	Buy	27,604 +699	+3%	+$71.6K	0.09%	187
2020 Q4	$2.41M	Sell	26,905 -2,056	-7%	-$189K	0.08%	181
2020 Q3	$2.99M	Buy	28,961 +402	+1%	+$43.3K	0.13%	144
2020 Q2	$2.26M	Buy	+28,559	New	+$2.13M	0.11%	160
2019 Q1	–	Sell	-16,882	Closed	-$1M	–	359
2018 Q4	$1M	Buy	+16,882	New	+$1.09M	0.07%	164

Other funds holding EBS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Granite Investment Partners's EBS Position: Q2 2021 in Review

Granite Investment Partners sold out of Emergent Biosolutions (EBS) in Q2 2021, closing a stake of 27,604 shares — an estimated $2.56M sold.

Granite Investment Partners first reported a position in EBS in Q4 2018 and held it in 5 quarters. The position peaked at $2.99M in Q3 2020. 290 funds tracked by Wall St. Rank hold EBS as of Q2 2021.

Granite Investment Partners reported no remaining Emergent Biosolutions position as of Q2 2021 after selling out during the quarter.
Granite Investment Partners sold 27,604 Emergent Biosolutions shares in Q2 2021, an estimated $2.56M.
Granite Investment Partners first reported a position in Emergent Biosolutions in Q4 2018 and held it in 5 quarters.
Granite Investment Partners's Emergent Biosolutions position peaked at $2.99M in Q3 2020.
290 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2021.

Based on Granite Investment Partners's 13F filing for Q2 2021, filed 30 Jul 2021.